FDA takes first step in possible reversal of ban on some peptides The Washington Post RFK Jr. and the Perils of Peptides Washington Monthly The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York GOP lawmakers ask RFK Jr. to make FDA unleash risky peptides like BPC 157 The Niche BPC 157, Semaglutide, And Wellness Peptides: What's Actually Allowed In California? Holt Law BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with